Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Theranostics | journal | 2.689 Q1 | 158 | 827 | 1327 | 56741 | 14448 | 1307 | 10.67 | 68.61 | 39.58 |  |
| 2 | International Journal of Nanomedicine | journal | 1.245 Q1 | 179 | 677 | 1913 | 41800 | 13310 | 1907 | 6.20 | 61.74 | 41.63 |  |
| 3 | Biomarker Insights | journal | 1.075 Q1 | 40 | 17 | 60 | 1317 | 292 | 59 | 5.85 | 77.47 | 39.68 | |
| 4 | Nanotechnology, Science and Applications | journal | 1.051 Q1 | 35 | 11 | 22 | 676 | 161 | 22 | 6.29 | 61.45 | 40.28 | |
| 5 | Infection and Drug Resistance | journal | 1.033 Q1 | 65 | 467 | 707 | 20216 | 2969 | 690 | 4.02 | 43.29 | 42.84 | |
| 6 | Drug Design, Development and Therapy | journal | 0.964 Q1 | 94 | 464 | 1080 | 20563 | 4661 | 1066 | 3.97 | 44.32 | 43.31 | |
| 7 | Patient Preference and Adherence | journal | 0.885 Q1 | 67 | 232 | 681 | 9520 | 1961 | 672 | 2.57 | 41.03 | 49.16 | |
| 8 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.853 Q2 | 64 | 478 | 396 | 21523 | 1297 | 387 | 2.99 | 45.03 | 44.22 | |
| 9 | Pharmacogenomics and Personalized Medicine | journal | 0.845 Q2 | 37 | 70 | 88 | 3488 | 348 | 87 | 4.04 | 49.83 | 50.00 | |
| 10 | Drug, Healthcare and Patient Safety | journal | 0.530 Q3 | 30 | 32 | 37 | 992 | 74 | 37 | 1.46 | 31.00 | 32.26 | |
| 11 | Fluoride - Quarterly Reports | journal | 0.254 Q4 | 51 | 37 | 128 | 1319 | 135 | 116 | 1.02 | 35.65 | 43.85 | |
| 12 | Open Access Journal of Clinical Trials | journal | 0.223 Q3 | 15 | 6 | 19 | 207 | 11 | 19 | 0.45 | 34.50 | 31.25 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data